<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0004095"><a href="http://purl.obolibrary.org/obo/MONDO_0004095">MONDO:0004095</a></h3>
<p><strong>Label:</strong> b-cell lymphoma</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0019438">MONDO:0019438</a> (AL amyloidosis), <a href="http://purl.obolibrary.org/obo/MONDO_0009693">MONDO:0009693</a> (multiple myeloma), <a href="http://purl.obolibrary.org/obo/MONDO_0007243">MONDO:0007243</a> (Burkitts lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0004948">MONDO:0004948</a> (chronic lymphocytic leukemia), <a href="http://purl.obolibrary.org/obo/MONDO_0018906">MONDO:0018906</a> (follicular lymphoma), <a href="http://purl.obolibrary.org/obo/MONDO_0007926">MONDO:0007926</a> (Waldenstrom macroglobulinemia), <a href="http://purl.obolibrary.org/obo/MONDO_0005615">MONDO:0005615</a> (plasmacytoma), <a href="http://purl.obolibrary.org/obo/MONDO_0000432">MONDO:0000432</a> (lymphoplasmacytic lymphoma),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://www.orpha.net/ORDO/Orphanet_33226">Orphanet:33226</a>, <a href="http://www.orpha.net/ORDO/Orphanet_29073">Orphanet:29073</a>, <a href="http://www.orpha.net/ORDO/Orphanet_86855">Orphanet:86855</a>, <a href="http://purl.obolibrary.org/obo/OMIM_153600">OMIM:153600</a>, <a href="http://purl.obolibrary.org/obo/OMIM_113970">OMIM:113970</a>, <a href="http://www.orpha.net/ORDO/Orphanet_85443">Orphanet:85443</a>, <a href="http://purl.obolibrary.org/obo/OMIM_151400">OMIM:151400</a>, <a href="http://www.orpha.net/ORDO/Orphanet_67038">Orphanet:67038</a>, <a href="http://purl.obolibrary.org/obo/OMIM_613024">OMIM:613024</a>, <a href="http://purl.obolibrary.org/obo/OMIM_610430">OMIM:610430</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612558">OMIM:612558</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612557">OMIM:612557</a>, <a href="http://purl.obolibrary.org/obo/OMIM_609630">OMIM:609630</a>, <a href="http://purl.obolibrary.org/obo/OMIM_254500">OMIM:254500</a>, <a href="http://www.orpha.net/ORDO/Orphanet_314701">Orphanet:314701</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612559">OMIM:612559</a>, <a href="http://purl.obolibrary.org/obo/OMIM_109543">OMIM:109543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_543">Orphanet:543</a>, <a href="http://www.orpha.net/ORDO/Orphanet_545">Orphanet:545</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) 41.36%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002665">HP:0002665</a> (Lymphoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0011842">HP:0011842</a> (Abnormality of skeletal morphology))) 41.11%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002665">HP:0002665</a> (Lymphoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000924">HP:0000924</a> (Abnormality of the skeletal system))) 41.11%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002665">HP:0002665</a> (Lymphoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0009121">HP:0009121</a> (Abnormal axial skeleton morphology))) 37.56%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0004377">HP:0004377</a> (Hematological neoplasm) and <a href="http://purl.obolibrary.org/obo/HP_0010978">HP:0010978</a> (Abnormality of immune system physiology) 35.92%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001871">HP:0001871</a> (Abnormality of blood and blood-forming tissues) 35.77%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002665">HP:0002665</a> (Lymphoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000164">HP:0000164</a> (Abnormality of the dentition))) 35.52%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0011793">HP:0011793</a> (Neoplasm by anatomical site) 34.20%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002664">HP:0002664</a> (Neoplasm) 33.84%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002665">HP:0002665</a> (Lymphoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000076">HP:0000076</a> (Vesicoureteral reflux))) 33.57%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0002665">HP:0002665</a> (Lymphoma) 33.24%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000118">HP:0000118</a> (Phenotypic abnormality) 31.68%</li>
<li>Thing 31.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0000001">HP:0000001</a> (All) 31.67%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0001881">HP:0001881</a> (Abnormality of leukocytes) 30.54%</li>
</ul>
</body>
</html>
